You are here

kidney disease

Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M

Fierce Biotech

Thu, 08/22/24 - 11:18 am

Chinook Therapeutics

venture capital

Versant Ventures

FDA approves Novartis' kidney disease drug

Reuters

Wed, 08/7/24 - 11:02 pm

paroxysmal nocturnal hemoglobinuria

Ardelyx sues US health department over kidney disease drug

Reuters

Wed, 07/17/24 - 09:10 pm

Novo's kidney disease drug fails to improve blood pressure in phase 3, spurring $816M loss

Fierce Biotech

Thu, 06/27/24 - 11:38 am

clinical trials

Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins

BioSpace

Tue, 05/28/24 - 10:47 am

IgA nephropathy

Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial

Reuters

Fri, 05/24/24 - 11:30 am

type 2 diabetes

Vertex moves kidney disease drug into late-stage testing

BioPharma Dive

Mon, 04/1/24 - 11:21 pm

Vertex Pharmaceuticals

Will Novo Nordisk Be a $1 Trillion Company by 2030?

Motley Fool

Tue, 01/30/24 - 10:40 am

Calliditas starts Phase II trial for rare kidney disease therapy

Clinical Trials Arena

Thu, 11/30/23 - 10:04 am

Calliditas Therapeutics

clinical trials

Alport syndrome

Travere Touts Phase III Kidney Disease Data for Filspari After Trial Failures

BioSpace

Mon, 11/6/23 - 09:57 am

Travere Therapeutics

clinical trials

As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease

Fierce Pharma

Fri, 11/3/23 - 10:53 am

Travere Therapeutics

IgA nephropathy

Omeros terminates kidney disease trial as therapy fails in late-stage study

Reuters

Mon, 10/16/23 - 10:15 am

clinical trials

Berger's disease

AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million

Forbes

Tue, 10/3/23 - 11:34 am

Novartis eyes accelerated FDA approval for iptacopan across multiple indications

Clinical Trials Arena

Mon, 10/2/23 - 10:14 am

clinical trials

IgA nephropathy

Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks

BioSpace

Thu, 09/21/23 - 06:34 pm

Travere Therapeutics

clinical trials

ProKidney drops $25.5M on North Carolina manufacturing site for cell therapy prospect

Fierce Pharma

Wed, 06/14/23 - 06:48 pm

drug manufacturing

Novartis to acquire kidney disease biotech Chinook for up to $3.5B

BioPharma Dive

Mon, 06/12/23 - 10:24 am

Chinook Therapeutics

HI-Bio's expectations elevated after pair of phase 2 readouts bolster autoimmune ambitions

Fierce Biotech

Tue, 04/11/23 - 11:36 am

Human Immunology Bioscience

Goldfinch Bio falls from the sky after failing to find a path forward for kidney treatments

Fierce Biotech

Sun, 01/29/23 - 01:22 pm

As Roche prepares to take a kidney disease drug into PhIII, Ionis fleshes out the data

Endpoints

Mon, 11/7/22 - 05:24 pm

Ionis Pharmaceuticals

Pages